• Info
  • Insider Ownership

Insider Trading & Ownership of William Aliski

Location
Novato, CA
Summary
The estimated net worth of William Aliski is at least $1,708,646 dollars as of 11 Jun 2024. William Aliski is the Director of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $1.62M. William Aliski is the Director of X4 Pharmaceuticals, Inc and owns shares of X4 Pharmaceuticals, Inc (XFOR) stock worth about $85.2K.
Signature
/s/ Adam S. Mostafa, attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow William Aliski and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • William Aliski has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,708,646.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Ultragenyx Pharmaceutical Inc. ($1,623,405).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of William Aliski

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RARE Ultragenyx Pharmaceutical Inc. Director $1,623,405 24 Jun 2021
XFOR X4 Pharmaceuticals, Inc Director $85,241 10 Jun 2024
AGTC APPLIED GENETIC TECHNOLOGIES CORP Director 30 Nov 2022

Insider Transactions Reported by William Aliski:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.